HRMY
Harmony Biosciences Holdings Inc.
Company Overview
| Mkt Cap | $1.49B | Price | $28.57 |
| Volume | 713.09K | Change | -1.14% |
| P/E Ratio | 10.2 | Open | $28.69 |
| Revenue | $714.7M | Prev Close | $28.90 |
| Net Income | $145.5M | 52W Range | $25.52 - $40.93 |
| Div Yield | N/A | Target | $43.91 |
| Overall | 67 | Value | 80 |
| Quality | -- | Technical | 54 |
No chart data available
Stock Overview
Updated DailyHarmony Biosciences Holdings Inc. (HRMY) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $28.57 with a market capitalization of $1.49 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows HRMY with a volume of 713K shares. The stock opened down 0.73% from yesterday's close of $28.90. Current analyst estimates project earnings of $3.2 per share for this year, with next year targeting $3.93.
HRMY demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for HRMY include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 53.7%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 04:42 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HRMY | $28.57 | -1.1% | 713.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Harmony Biosciences Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW